Navigation Links
ViroPharma to Release 2011 Second Quarter Financial Results on July 28, 2011
Date:7/21/2011

EXTON, Pa., July 21, 2011 /PRNewswire/ -- ViroPharma Incorporated's (Nasdaq: VPHM) second quarter financial results for 2011 are expected to be released on Thursday, July 28, 2011 before the open of the U.S. financial markets.

The company will host a conference call and live audio webcast at 9:00 a.m. Eastern Time on the same day.  During the conference call, ViroPharma management will discuss the 2011 second quarter financial results and other business.

The press release and the live webcast of the conference call will be accessible via ViroPharma's corporate website at http://www.viropharma.com.  An audio archive will be available at the same address until August 18, 2011.  To participate in the conference call, please dial (888) 299-4099 (domestic) and (302) 709-8337 (international).  After placing the call, please tell the operator you wish to join the ViroPharma investor conference call.  

About ViroPharma Incorporated

ViroPharma Incorporated is an international biopharmaceutical company committed to developing and commercializing novel solutions for physician specialists to address unmet medical needs of patients living with diseases that have few if any clinical therapeutic options.  Our goal is to provide rewarding careers to employees, to create new standards of care in the way serious diseases are treated, and to build international partnerships with the patients, advocates, and health care professionals we serve. 

ViroPharma routinely posts information, including press releases, which may be important to investors in the investor relations and media sections of our company's website, http://www.viropharma.com/. The company encourages investors to consult these sections for more information on ViroPharma and
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. ViroPharma to Present at Three September Healthcare Conferences
2. ViroPharma to Present at Three October Healthcare Conferences
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
5. ViroPharma to Present at Three November Healthcare Conferences
6. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
7. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
8. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
9. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
10. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
11. ViroPharma to Present at Two June Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/22/2014)... July 22, 2014 Dr. Williams says, ... who have recognized that the greatest health care system ... too often needlessly deadly while trying to serve the ... quasi-experts seeking to transform an enormous system that none ... Williams, in his continuing series of Open Letters ( ...
(Date:7/21/2014)... University,s College of Arts and Sciences has received ... stainless nanoparticles. , Mathew M. Maye, associate professor ... grant from the National Science Foundation (NSF). The ... alloy nanostructures, the results of which may impact ... , Maye,s approach is novel, in ...
(Date:7/21/2014)... Sleep disturbances such as insomnia, hypersomnia, ... depression. According to a study published by the ... of depressed patients have insomnia symptoms, and hypersomnia ... adults and 10% of older patients, with a ... have a major impact on quality of life, ...
(Date:7/18/2014)... Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that ... operating results on Tuesday, August 5, 2014, before the ... conference call and simultaneous webcast at 8:30 AM Eastern ... access this call, dial (888) 660-6127 (U.S.) or (973) ... accessed from the ,Events and Presentations, page of Regeneron,s ...
Breaking Biology Technology:Dr. Ira Williams Asks What’s Wrong With Jonathan Bush’s Book, Where Does It Hurt? 2Syracuse University chemist to use NSF grant to study materials chemistry, nanoscience 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 2Open Label Data on Enhanced Sleep Released by JayMac Pharmaceuticals, LLC 3
... biotech infrastructure has prompted a Minnesota company to consider ... could employ approximately 200 people. , , Excorp Medical ... Wisconsin to manufacture systems used to treat human liver ... a product that company representatives say has the potential ...
... and growth of the medical device industry and some of ... the leading players in this $100 billion industry. , , ... this table, here are a couple interesting observations: , , ... business (with the exception of the imaging market), which includes ...
... more Wisconsin companies are expected to pitch their businesses ... , ,Eight companies from Wisconsin are now listed as ... will be in Minneapolis. , ,The forum, created ... and the Biotechnology Industry Organization, annually showcases biotech and ...
Cached Biology Technology:Minneapolis company sets sights on southern Wisconsin 2Minneapolis company sets sights on southern Wisconsin 3Midwest plays key role in developing new medical device companies 2Midwest plays key role in developing new medical device companies 3Three more Wisconsin firms to present at venture forum 2
(Date:7/22/2014)... split light with uncanny precision are key parts ... that manipulate light instead of electricity. But producing ... them with a precise beam of electrons, is ... at Princeton and Columbia universities have proposed a ... and grow these specialized materials, known as photonic ...
(Date:7/22/2014)... -- Stem cells offer much promise for treating damaged ... cell survival is poor, limiting their effectiveness. New methods ... and optimize their therapeutic function after transplantation, as described ... , a peer-reviewed journal from Mary Ann Liebert, Inc., ... BioResearch Open Access website . , ...
(Date:7/22/2014)... NY -- As part of a multinational, collaborative effort, ... Sinai have helped identify over 100 locations in the ... in the largest genomic study published on any psychiatric ... published online in Nature , point to biological ... lead to new approaches to treating the disorder, which ...
Breaking Biology News(10 mins):Technique simplifies the creation of high-tech crystals 2Technique simplifies the creation of high-tech crystals 3Mount Sinai scientists and international team shed new light on schizophrenia 2Mount Sinai scientists and international team shed new light on schizophrenia 3
... UK has been given the go-ahead to explore one of ... deep beneath Antarctica,s ice sheet. Buried under 3 km of ... may have been isolated for hundreds of thousands of ... hopes the exploration will yield vital clues about life on ...
... Moose has developed a corn plant with enormous potential for ... Moose said, due to a greater number of leaves and ... crop. The gene known as Glossy 15 was originally ... coating that acts like a sun screen for the young ...
... survey of airborne fungi and fungal spores found in Eastern ... cause of the high incidence of childhood asthma in this ... issue of the International Journal of Environmental Technology and ... human factors that lead to high levels of such fungi. ...
Cached Biology News:Final frontier: Mission to explore buried ancient Antarctic lake given green light 2Doubling a gene in corn results in giant biomass 2Airborne asthma allergens 2
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rad51, N-terminal...
Phospho-mu-Opioid Receptor (Ser375) Antibody...
Rabbit polyclonal to WWOX8 ( Abpromise for all tested applications). entrezGeneID: 51741 SwissProtID: Q9NZC7-8...
Biology Products: